Hivid for HIV/AIDS

Browse eMedTV's wide range of articles related to hivid for hiv/aids including topics such as hivid and pregnancy, hivid warnings and precautions, and hivid dosage. Use the search box at the top-right corner of the page to find information about other health topics.

 Read About 
 
Description of Articles in Hivid for HIV/AIDS

A healthcare provider may prescribe Hivid as part of a treatment plan for HIV or AIDS. This eMedTV article provides an overview of Hivid, explaining how the drug works, possible side effects, and tips for when and how to take the medication.

Some of the most commonly reported Hivid side effects include nausea, fatigue, and diarrhea. This eMedTV Web page also takes an in-depth look at some of the more serious side effects, such as seizures, unusual bleeding or bruising, and depression.

Hivid is used for the treatment of HIV and AIDS in adults and adolescents. This eMedTV page explains how Hivid uses also extend to preventing HIV infection in people exposed to the virus (such as accidents involving a contaminated needle).

This eMedTV Web page explains that the recommended Hivid dosage when treating HIV or AIDS is 0.75 mg three times a day (every eight hours). This page also covers general Hivid dosing guidelines and offers some tips for taking the medication.

This eMedTV resource explores potential Hivid drug interactions with other drugs, such as certain antibiotics and some antacids. This page also covers how these interactions can increase your risk of side effects or cause Hivid to be less effective.

Hivid appears to increase the risk of lymphoma (a certain cancer) and congestive heart failure. This part of the eMedTV archives takes an in-depth look at several Hivid warnings and precautions, including who should not take the medication.

This part of the eMedTV Web site describes possible symptoms of a Hivid overdose, such as vomiting, fever, and unusual sensations (such as burning or numbness). This page also covers possible treatment options and factors that affect overdose effects.

This eMedTV page explains why it is not known if it is safe to take Hivid during pregnancy. This page also discusses the results of animal studies involving Hivid and pregnancy, and explains why Hivid is classified as a pregnancy Category C medicine.

It is not known if Hivid passes through breast milk. This portion of the eMedTV library explains that there has been no research done on Hivid and breastfeeding, and discusses why it is generally recommended that women with HIV avoid breastfeeding.

As this portion of the eMedTV library explains, Hivid is protected by a patent that prevents any generic version of the drug from being manufactured. The earliest date that a generic Hivid could become available is July 2008, when the patent expires.